Parechovirus A Circulation and Testing Capacities in Europe, 2015–2021

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Parechovirus A Circulation and Testing Capacities in Europe, 2015–2021. / Bubba, Laura; Broberg, Eeva K.; Fischer, Thea K.; Simmonds, Peter; Harvala, Heli.

I: Emerging Infectious Diseases, Bind 30, Nr. 2, 2024, s. 234-244.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Bubba, L, Broberg, EK, Fischer, TK, Simmonds, P & Harvala, H 2024, 'Parechovirus A Circulation and Testing Capacities in Europe, 2015–2021', Emerging Infectious Diseases, bind 30, nr. 2, s. 234-244. https://doi.org/10.3201/eid3002.230647

APA

Bubba, L., Broberg, E. K., Fischer, T. K., Simmonds, P., & Harvala, H. (2024). Parechovirus A Circulation and Testing Capacities in Europe, 2015–2021. Emerging Infectious Diseases, 30(2), 234-244. https://doi.org/10.3201/eid3002.230647

Vancouver

Bubba L, Broberg EK, Fischer TK, Simmonds P, Harvala H. Parechovirus A Circulation and Testing Capacities in Europe, 2015–2021. Emerging Infectious Diseases. 2024;30(2):234-244. https://doi.org/10.3201/eid3002.230647

Author

Bubba, Laura ; Broberg, Eeva K. ; Fischer, Thea K. ; Simmonds, Peter ; Harvala, Heli. / Parechovirus A Circulation and Testing Capacities in Europe, 2015–2021. I: Emerging Infectious Diseases. 2024 ; Bind 30, Nr. 2. s. 234-244.

Bibtex

@article{82d28c7576924ca58baafd5517f28a8d,

title = "Parechovirus A Circulation and Testing Capacities in Europe, 2015–2021",

abstract = "Parechovirus infections usually affect neonates and young children; manifestations vary from asymptomatic to life-threatening. We describe laboratory capacity in Europe for assessing parechovirus circulation, seasonality, and epidemiology. We used retrospective anonymized data collected from parechovirus infection case-patients identified in Europe during January 2015–December 2021. Of 21 laboratories from 18 countries that participated in the study, 16 (76%) laboratories with parechovirus detection capacity reported 1,845 positive samples; 12/16 (75%) with typing capability successfully identified 517 samples. Parechovirus A3 was the most common type (n = 278), followed by A1 (153), A6 (50), A4 (13), A5 (22), and A14 (1). Clinical data from 1,269 participants highlighted correlation of types A3, A4, and A5 with severe disease in neonates. We observed a wide capacity in Europe to detect, type, and analyze parechovirus data. To enhance surveillance and response for PeV outbreaks, sharing typing protocols and data on parechoviruspositive cases should be encouraged.",

author = "Laura Bubba and Broberg, {Eeva K.} and Fischer, {Thea K.} and Peter Simmonds and Heli Harvala",

year = "2024",

doi = "10.3201/eid3002.230647",

language = "English",

volume = "30",

pages = "234--244",

journal = "Emerging Infectious Diseases (Online)",

issn = "1080-6040",

publisher = "U.S. Department of Health and Human Services Centers for Disease Control and Prevention",

number = "2",

}

RIS

TY - JOUR

T1 - Parechovirus A Circulation and Testing Capacities in Europe, 2015–2021

AU - Bubba, Laura

AU - Broberg, Eeva K.

AU - Fischer, Thea K.

AU - Simmonds, Peter

AU - Harvala, Heli

PY - 2024

Y1 - 2024

N2 - Parechovirus infections usually affect neonates and young children; manifestations vary from asymptomatic to life-threatening. We describe laboratory capacity in Europe for assessing parechovirus circulation, seasonality, and epidemiology. We used retrospective anonymized data collected from parechovirus infection case-patients identified in Europe during January 2015–December 2021. Of 21 laboratories from 18 countries that participated in the study, 16 (76%) laboratories with parechovirus detection capacity reported 1,845 positive samples; 12/16 (75%) with typing capability successfully identified 517 samples. Parechovirus A3 was the most common type (n = 278), followed by A1 (153), A6 (50), A4 (13), A5 (22), and A14 (1). Clinical data from 1,269 participants highlighted correlation of types A3, A4, and A5 with severe disease in neonates. We observed a wide capacity in Europe to detect, type, and analyze parechovirus data. To enhance surveillance and response for PeV outbreaks, sharing typing protocols and data on parechoviruspositive cases should be encouraged.

AB - Parechovirus infections usually affect neonates and young children; manifestations vary from asymptomatic to life-threatening. We describe laboratory capacity in Europe for assessing parechovirus circulation, seasonality, and epidemiology. We used retrospective anonymized data collected from parechovirus infection case-patients identified in Europe during January 2015–December 2021. Of 21 laboratories from 18 countries that participated in the study, 16 (76%) laboratories with parechovirus detection capacity reported 1,845 positive samples; 12/16 (75%) with typing capability successfully identified 517 samples. Parechovirus A3 was the most common type (n = 278), followed by A1 (153), A6 (50), A4 (13), A5 (22), and A14 (1). Clinical data from 1,269 participants highlighted correlation of types A3, A4, and A5 with severe disease in neonates. We observed a wide capacity in Europe to detect, type, and analyze parechovirus data. To enhance surveillance and response for PeV outbreaks, sharing typing protocols and data on parechoviruspositive cases should be encouraged.

U2 - 10.3201/eid3002.230647

DO - 10.3201/eid3002.230647

M3 - Journal article

C2 - 38270192

AN - SCOPUS:85183576598

VL - 30

SP - 234

EP - 244

JO - Emerging Infectious Diseases (Online)

JF - Emerging Infectious Diseases (Online)

SN - 1080-6040

IS - 2

ER -

ID: 389841824

Institut for Idræt og Ernæring